City
Epaper

Vaccine for cervical cancer prevention to be available in small quantity in 2023, increased next year: Adar Poonawalla

By ANI | Published: January 25, 2023 4:17 PM

A day after the launch of the first made-in-India Human Papillomavirus (HPV) "CERVAVAC" vaccine for the prevention of cervical ...

Open in App

A day after the launch of the first made-in-India Human Papillomavirus (HPV) "CERVAVAC" vaccine for the prevention of cervical cancer, Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla on Wednesday said that the availability of the vaccine will be little in number this year, however, it would be boosted next year.

Poonawalla briefed Union Health Minister Mansukh Mandaviya about the HPV vaccine in the national capital.

Speaking toafter the meeting, the SII CEO said, "I had come to brief the Union Health minister about it. We'll wait for the government program to roll out. Capacity is very small this year but we'll build a large capacity to take care of the entire nation's needs for next year."

Talking about the rollout programme of the vaccine, Poonawalla said that it would be done through government programmes this year.

"We will slowly roll it out through government programs this year. I can't comment on pricing now. We will wait for tendering process and follow government protocols," he said.

On Tuesday Serum Institute of India launched first made-in-India HPV vaccine for cervical cancer.

Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla, announced the launch of the first made-in-India Human Papillomavirus (HPV) "CERVAVAC" vaccine, for the prevention of cervical cancer.

The launch took place in the presence of Home Minister Amit Shah, Adar Poonawalla, and the Director of Government & Regulatory Affairs at Serum Institute of India, Prakash K Singh.

"On the occasion of India's National Girl Child Day and Cervical Cancer Awareness Month, @SerumInstIndia is pleased to launch the first made-in-India HPV vaccine by the hands of our Hon'ble Home Minister Shri @AmitShah Ji. @PrakashKsingh7," tweeted Adar Poonawalla.

'CERVAVAC' is an outcome of a partnership of DBT and BIRAC with the Bill and Melinda Gates Foundation, supported by Serum Institute of India Private Limited for the indigenous development of quadrivalent vaccine through its partnership programme 'Grand Challenges India'.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Mansukh MandaviyaSIISerum Institute Of IndiaSerum institute of india pvt. ltdAdar PoonawallaSerum indiaSerum institute of india private ltd.India serum institute of indiaSerum institute indiaSerum institute of india private limited
Open in App

Related Stories

NationalCovishield Vaccine Side Effect: Serum Institute Faces Legal Action As Parents of Deceased Girls Prepare Lawsuit

Social ViralCovishield Funny Memes Go Viral After AstraZeneca Admits Its COVID-19 Vaccine Can Cause Rare Side Effects

NationalMansukh Mandaviya Inaugurates NIPER in Guwahati

MaharashtraTMC remains vigilant amid a recent upsurge in COVID-19 cases and detection of JN.1 variant in India

National“Need to be alert, but…”: Health Minister Mansukh Mandaviya after review meeting amid rise in Covid cases

National Realted Stories

NationalSIA raids 11 locations in Kashmir in connection with non-local’s murder

National7,000 more police personnel required for effective policing in Kerala

NationalFire Breaks Out at Income Tax Department Building in Delhi, 21 Fire Tenders On Spot (Watch Video)

NationalIndia bloc will form government at Centre: Karnataka Deputy CM Shivakumar

NationalCSIR-NIIST joins hands with NIT-Calicut to promote research in cutting-edge domains